Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
Go back to Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device| (NYSE: OGN) | Delayed: 13.68 -0.01 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.69 | 52 Week High | $8.00 | |||
| Open | $13.68 | 52 Week Low | $8.00 | |||
| Day High | $13.70 | P/E | N/A | |||
| Day Low | $13.68 | EPS | $0.00 | |||
| Volume | 4,941,532 | |||||
